A US-based nephrologist and national health plan CMO shares perspectives on IgAN epidemiology, patient classification, the treatment journey, payer coverage in the US, and areas of unmet need, including views on emerging therapies.

This interview was conducted on April 03, 2026.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.